(CRAI) CRA International - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US12618T1051
Consulting, Litigation, Economics, Strategy
Dividends
| Dividend Yield | 1.34% |
| Yield on Cost 5y | 5.48% |
| Yield CAGR 5y | 16.50% |
| Payout Consistency | 100.0% |
| Payout Ratio | 24.9% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 31.0% |
| Value at Risk 5%th | 47.6% |
| Relative Tail Risk | -6.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.02 |
| Alpha | -11.61 |
| CAGR/Max DD | 0.61 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.598 |
| Beta | 0.704 |
| Beta Downside | 0.934 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.06% |
| Mean DD | 11.28% |
| Median DD | 11.34% |
Description: CRAI CRA International November 17, 2025
CRA International Inc. (NASDAQ:CRAI) is a Boston-based global consulting firm that delivers economic, financial, and management advisory services. Its core offerings span litigation and regulatory support-including expert testimony, forensic accounting, and insurance analysis-as well as strategic consulting such as performance improvement, ESG and sustainability strategy, market demand estimation, and intellectual-property valuation.
In FY 2023 the company generated roughly $1.1 billion in revenue, posting an operating margin of about 15% and a diluted EPS of $3.45, reflecting steady demand for litigation-related consulting amid heightened regulatory scrutiny. Revenue growth has been modest (≈5% YoY), driven largely by expanding ESG and blockchain-crypto advisory work, sectors where corporate spending is rising faster than the broader consulting market. The firm’s diversified client base-covering finance, healthcare, energy, technology, and consumer goods-helps mitigate concentration risk and positions CRA to benefit from macro trends such as increased corporate governance compliance and the acceleration of digital asset adoption.
For a deeper, data-driven view of CRA’s valuation dynamics and how its key drivers compare to peers, you might explore the analyst tools on ValueRay to complement this high-level overview.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (56.6m TTM) > 0 and > 6% of Revenue (6% = 43.9m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 0.39pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.52% (prev 2.57%; Δ -7.09pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 41.8m <= Net Income 56.6m (YES >=105%, WARN >=100%) |
| Net Debt (171.8m) to EBITDA (113.6m) ratio: 1.51 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.90 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (6.62m) change vs 12m ago -3.24% (target <= -2.0% for YES) |
| Gross Margin 31.00% (prev 28.56%; Δ 2.44pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 120.7% (prev 115.5%; Δ 5.20pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 16.96 (EBITDA TTM 113.6m / Interest Expense TTM 4.99m) >= 6 (WARN >= 3) |
Altman Z'' 2.19
| (A) -0.05 = (Total Current Assets 305.6m - Total Current Liabilities 338.6m) / Total Assets 629.0m |
| (B) 0.34 = Retained Earnings (Balance) 211.7m / Total Assets 629.0m |
| (C) 0.14 = EBIT TTM 84.6m / Avg Total Assets 605.7m |
| (D) 0.47 = Book Value of Equity 201.7m / Total Liabilities 427.4m |
| Total Rating: 2.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.09
| 1. Piotroski 7.0pt |
| 2. FCF Yield 2.15% |
| 3. FCF Margin 3.89% |
| 4. Debt/Equity 0.96 |
| 5. Debt/Ebitda 1.51 |
| 6. ROIC - WACC (= 13.56)% |
| 7. RoE 27.01% |
| 8. Rev. Trend 94.55% |
| 9. EPS Trend 64.31% |
What is the price of CRAI shares?
As of December 06, 2025, the stock is trading at USD 189.31 with a total of 68,166 shares traded.
Over the past week, the price has changed by +7.36%, over one month by -0.01%, over three months by -2.22% and over the past year by +2.46%.
Over the past week, the price has changed by +7.36%, over one month by -0.01%, over three months by -2.22% and over the past year by +2.46%.
Is CRAI a buy, sell or hold?
CRA International has received a consensus analysts rating of 3.50.
Therefor, it is recommend to hold CRAI.
- Strong Buy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CRAI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 249.5 | 31.8% |
| Analysts Target Price | 249.5 | 31.8% |
| ValueRay Target Price | 215.8 | 14% |
CRAI Fundamental Data Overview November 26, 2025
Market Cap USD = 1.15b (1.15b USD * 1.0 USD.USD)
P/E Trailing = 20.9868
P/E Forward = 19.9601
P/S = 1.5745
P/B = 5.7769
P/EG = 1.48
Beta = 0.911
Revenue TTM = 731.1m USD
EBIT TTM = 84.6m USD
EBITDA TTM = 113.6m USD
Long Term Debt = 99.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 113.7m USD (from shortTermDebt, last quarter)
Debt = 194.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 171.8m USD (from netDebt column, last quarter)
Enterprise Value = 1.32b USD (1.15b + Debt 194.3m - CCE 22.5m)
Interest Coverage Ratio = 16.96 (Ebit TTM 84.6m / Interest Expense TTM 4.99m)
FCF Yield = 2.15% (FCF TTM 28.4m / Enterprise Value 1.32b)
FCF Margin = 3.89% (FCF TTM 28.4m / Revenue TTM 731.1m)
Net Margin = 7.74% (Net Income TTM 56.6m / Revenue TTM 731.1m)
Gross Margin = 31.00% ((Revenue TTM 731.1m - Cost of Revenue TTM 504.4m) / Revenue TTM)
Gross Margin QoQ = 27.40% (prev 31.22%)
Tobins Q-Ratio = 2.10 (Enterprise Value 1.32b / Total Assets 629.0m)
Interest Expense / Debt = 0.90% (Interest Expense 1.75m / Debt 194.3m)
Taxrate = 29.28% (4.75m / 16.2m)
NOPAT = 59.8m (EBIT 84.6m * (1 - 29.28%))
Current Ratio = 0.90 (Total Current Assets 305.6m / Total Current Liabilities 338.6m)
Debt / Equity = 0.96 (Debt 194.3m / totalStockholderEquity, last quarter 201.7m)
Debt / EBITDA = 1.51 (Net Debt 171.8m / EBITDA 113.6m)
Debt / FCF = 6.05 (Net Debt 171.8m / FCF TTM 28.4m)
Total Stockholder Equity = 209.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.00% (Net Income 56.6m / Total Assets 629.0m)
RoE = 27.01% (Net Income TTM 56.6m / Total Stockholder Equity 209.5m)
RoCE = 27.38% (EBIT 84.6m / Capital Employed (Equity 209.5m + L.T.Debt 99.3m))
RoIC = 21.02% (NOPAT 59.8m / Invested Capital 284.5m)
WACC = 7.46% (E(1.15b)/V(1.35b) * Re(8.61%) + D(194.3m)/V(1.35b) * Rd(0.90%) * (1-Tc(0.29)))
Discount Rate = 8.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.14%
[DCF Debug] Terminal Value 74.54% ; FCFE base≈26.7m ; Y1≈24.1m ; Y5≈20.8m
Fair Price DCF = 51.59 (DCF Value 338.6m / Shares Outstanding 6.56m; 5y FCF grow -12.14% → 3.0% )
EPS Correlation: 64.31 | EPS CAGR: 17.09% | SUE: 1.03 | # QB: 1
Revenue Correlation: 94.55 | Revenue CAGR: 8.96% | SUE: 0.92 | # QB: 2
EPS next Quarter (2026-03-31): EPS=2.25 | Chg30d=+0.040 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=8.91 | Chg30d=+0.187 | Revisions Net=+2 | Growth EPS=+8.1% | Growth Revenue=+3.7%
P/E Trailing = 20.9868
P/E Forward = 19.9601
P/S = 1.5745
P/B = 5.7769
P/EG = 1.48
Beta = 0.911
Revenue TTM = 731.1m USD
EBIT TTM = 84.6m USD
EBITDA TTM = 113.6m USD
Long Term Debt = 99.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 113.7m USD (from shortTermDebt, last quarter)
Debt = 194.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 171.8m USD (from netDebt column, last quarter)
Enterprise Value = 1.32b USD (1.15b + Debt 194.3m - CCE 22.5m)
Interest Coverage Ratio = 16.96 (Ebit TTM 84.6m / Interest Expense TTM 4.99m)
FCF Yield = 2.15% (FCF TTM 28.4m / Enterprise Value 1.32b)
FCF Margin = 3.89% (FCF TTM 28.4m / Revenue TTM 731.1m)
Net Margin = 7.74% (Net Income TTM 56.6m / Revenue TTM 731.1m)
Gross Margin = 31.00% ((Revenue TTM 731.1m - Cost of Revenue TTM 504.4m) / Revenue TTM)
Gross Margin QoQ = 27.40% (prev 31.22%)
Tobins Q-Ratio = 2.10 (Enterprise Value 1.32b / Total Assets 629.0m)
Interest Expense / Debt = 0.90% (Interest Expense 1.75m / Debt 194.3m)
Taxrate = 29.28% (4.75m / 16.2m)
NOPAT = 59.8m (EBIT 84.6m * (1 - 29.28%))
Current Ratio = 0.90 (Total Current Assets 305.6m / Total Current Liabilities 338.6m)
Debt / Equity = 0.96 (Debt 194.3m / totalStockholderEquity, last quarter 201.7m)
Debt / EBITDA = 1.51 (Net Debt 171.8m / EBITDA 113.6m)
Debt / FCF = 6.05 (Net Debt 171.8m / FCF TTM 28.4m)
Total Stockholder Equity = 209.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.00% (Net Income 56.6m / Total Assets 629.0m)
RoE = 27.01% (Net Income TTM 56.6m / Total Stockholder Equity 209.5m)
RoCE = 27.38% (EBIT 84.6m / Capital Employed (Equity 209.5m + L.T.Debt 99.3m))
RoIC = 21.02% (NOPAT 59.8m / Invested Capital 284.5m)
WACC = 7.46% (E(1.15b)/V(1.35b) * Re(8.61%) + D(194.3m)/V(1.35b) * Rd(0.90%) * (1-Tc(0.29)))
Discount Rate = 8.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.14%
[DCF Debug] Terminal Value 74.54% ; FCFE base≈26.7m ; Y1≈24.1m ; Y5≈20.8m
Fair Price DCF = 51.59 (DCF Value 338.6m / Shares Outstanding 6.56m; 5y FCF grow -12.14% → 3.0% )
EPS Correlation: 64.31 | EPS CAGR: 17.09% | SUE: 1.03 | # QB: 1
Revenue Correlation: 94.55 | Revenue CAGR: 8.96% | SUE: 0.92 | # QB: 2
EPS next Quarter (2026-03-31): EPS=2.25 | Chg30d=+0.040 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=8.91 | Chg30d=+0.187 | Revisions Net=+2 | Growth EPS=+8.1% | Growth Revenue=+3.7%
Additional Sources for CRAI Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle